Pharmaceutical Company and Representative Image Survey
Sample / Survey Details
Sample size/respondent type: n = 460 (200 GPs and 260 Hospital Consultants)
Sample type: GPs = nationally representative, quota-controlled by SHA region and qualifying age. Hospital Consultants = quota-controlled by type of specialty (17 leading specialties covered)
Methodology:
Online. Structured questionnaire – please see below for details
Timings:
Fieldwork in early August. Final results available late August
Deliverables:
PowerPoint charts including bullet point summary of key findings, correspondence/correlation analysis maps and computer tables
Final results can be purchased for GPs only, Hospital Consultants only or for both GPs and Hospital Consultants. NB: If data sets for both respondent types are purchased then a 20% discount would apply on the total price.
Back data on GPs (only) also available to purchase from a similar survey in 2006
Costs:
For details of costs, please contact:
Gary King
+44 (0) 20 7890 9153
Main areas covered by the survey are:-
Company Image:
Overall sample split into two for assessing each profiled company
| Sub-sample A (each assessed by 100 GPs and 130 Consultants) | Sub-sample B (each assessed by 100 GPs and 130 Consultants) |
| Lilly | Janssen-Cilag |
| Roche | GlaxoSmithKline |
| Boehringer Ingelheim | Wyeth |
| Bristol-Myers Squibb | Leo |
| Sanofi Aventis | AstraZeneca |
| Sanofi Pasteur | Pfizer |
| Merck Serono | Novartis |
| MSD | GE Healthcare |
| Bayer Schering | Astellas |
| Schering Plough | Organon |
| Abbott Labs | |
| Servier | |
Overview impression of each company profiled
Perceived importance of the following 10 company characteristics
- Innovation
- Value for money
- Highly priced products
- Caring
- Research based
- Promotes their products aggressively
- Educational
- Ethical
- High quality products
- Provides 'added value' services
Level of agreement with each of the 10 company characteristics above for each company profiled
Representative Image:
Overall sample split into two for assessing each profiled company
| Sub-sample A (each assessed by 100 GPs and 130 Consultants) | Sub-sample B (each assessed by 100 GPs and 130 Consultants) |
| Lilly | Janssen-Cilag |
| Roche | GlaxoSmithKline |
| Boehringer Ingelheim | Wyeth |
| Bristol-Myers Squibb | Leo |
| Sanofi Aventis | AstraZenica |
| Sanofi Pasteur | Pfizer |
| Merck Pharmaceuticals | Novartis |
| MSD | GE Healthcare |
| Schering Health Care | Astellas |
| Schering Plough | Organon |
| Abbott Labs | Bayer Pharma |
| Servier | Serono |
Number of reps seen in an average month & the number seen from each company profiled
Overall impression of each profiled company representatives sales force
Perceived importance of the following 9 company rep characteristics:
- Has good product knowledge
- Ability to answer questions
- Ability to handle objections
- Presentations/discussions are of a high standard
- Presents balanced arguments
- Good rapport
- Patient-focused
- Follows up on queries/requests
- Understands my/the practice needs
Level of agreement with each of the company rep characteristics above for each company profiled.
Style of communication preferred from a company rep
Which materials deemed useful during and after a rep visit
Overall importance of the rep in influencing brand choice